NSYS · Nortech Systems Inc

$12.31 +0.53 (+4.50%) At close · Aug 27

Market Cap

$33.96M

2.85M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$12.22M -15%

FY2025

Net Income

-$252K +80.5%

FY2025

Gross Margin

147.36% +31pp

FY2025

Operating Margin

7.98% +9.3pp

FY2025

Diluted EPS

-$0.09 +80.9%

FY2025

Operating Cash Flow

$2.74M +221.9%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Revenue	-55.0%	-34.9%	-20.1%	-$14K	$12.22M	$14.37M	$13.43M	$134.12M	$115.17M	$104.11M	$116.33M	$113.37M	$112.34M	$116.62M	$115.19M	$112.04M	$111.06M	$106.94M	$114.24M	$99.82M
Cost of Revenue	-4.1%	+1.2%	-0.3%	$104.16M	$100.36M	$111.41M	$116.23M	$113.64M	$99.3M	$94.44M	$103.76M	$100.06M	$100.22M	$102.78M	$103.13M	$98.71M	$97.94M	$94.54M	$100.89M	$88.39M
Gross Profit	-4.2%	+13.3%	+4.1%	$20.5M	$18.01M	$16.72M	$23.1M	$20.48M	$15.86M	$9.67M	$12.58M	$13.31M	$12.12M	$13.84M	$12.06M	$13.33M	$13.12M	$12.39M	$13.34M	$11.43M
Gross Margin	—	—	—	—	147.36%	116.36%	172.03%	15.27%	13.77%	9.28%	10.81%	11.74%	10.79%	11.87%	10.47%	11.9%	11.81%	11.59%	11.68%	11.45%
Research & Development	-7.1%	—	—	$1.2M	$1.17M	$1.19M	$1.2M	$1.46M	$483K	$0	—	—	—	—	—	—	—	—	—	—
General & Administrative	-1.9%	+3.1%	+4.1%	$11.55M	$10.79M	$11.71M	$12.35M	$11.43M	$10M	$9.25M	$9.63M	$8.43M	$8.09M	$8.26M	$7.23M	$6.94M	$6.86M	$6.64M	$8.19M	$7.08M
Amortization of Intangibles	-50.7%	-37.6%	-15.6%	—	$18K	$89K	$159K	$150K	$176K	$191K	$219K	$219K	$237K	$190.65K	$97.98K	$5292	$5291	$16.57K	$140.6K	—
Restructuring Charges	—	—	—	—	$266K	$571K	—	$0	$327K	$0	—	—	—	—	—	—	—	—	—	—
Total Operating Expenses	+0.9%	+10.6%	+3.2%	$17.98M	$17.03M	$16.92M	$17.15M	$16.59M	$13.59M	$10.28M	$12.35M	$12.06M	$13.39M	$13.21M	$12.48M	$12M	$11.66M	$10.93M	$11.83M	$10.2M
Operating Income	-36.9%	—	—	$2.52M	$975K	-$195K	$5.95M	$3.89M	$2.27M	-$616K	$224K	$1.25M	-$1.27M	$629.06K	-$422.05K	$1.33M	$1.46M	$1.46M	$1.51M	$1.23M
Operating Margin	—	—	—	—	7.98%	-1.36%	44.33%	2.9%	1.97%	-0.59%	0.19%	1.1%	-1.13%	0.54%	-0.37%	1.19%	1.31%	1.37%	1.32%	1.23%
Interest Expense	+32.9%	+9.2%	+7.6%	$946K	$964K	$744K	$487K	$411K	$430K	$620K	$1.04M	$757K	$628K	$550.29K	$465.37K	$367.59K	$388.79K	$440.18K	$511.33K	$429.12K
Other Non-Operating Income	—	—	—	—	—	—	-$487K	-$411K	$5.74M	-$620K	—	—	—	—	—	-$367.59K	-$367.66K	-$533.16K	$238.56K	-$348.43K
Pretax Income	-85.3%	—	—	$1.57M	$11K	-$939K	$5.47M	$3.48M	$8.01M	-$1.24M	-$819K	$492K	-$2.07M	$78.77K	-$887.42K	$961.02K	$1.09M	$927.44K	$1.75M	$881.77K
Income Tax	-43.6%	-3.2%	—	$537K	$263K	$356K	-$1.41M	$1.47M	$859K	$310K	$409K	$326K	$375K	$35K	-$316K	$81K	$300K	$298K	$561K	$375K
Net Income	—	—	—	$1.03M	-$252K	-$1.3M	$6.87M	$2.01M	$7.15M	-$1.55M	-$1.23M	$166K	-$2.45M	$43.77K	-$571.42K	$880.02K	$787.38K	$629.44K	$1.19M	$506.77K
Net Margin	—	—	—	—	-2.06%	-9.01%	51.18%	1.5%	6.21%	-1.49%	-1.06%	0.15%	-2.18%	0.04%	-0.5%	0.79%	0.71%	0.59%	1.04%	0.51%
Comprehensive Income	-78.4%	—	—	$1.26M	$16K	-$1.74M	$6.71M	$1.58M	$7.25M	-$1.33M	-$1.25M	$34K	-$2.5M	—	—	—	—	—	—	—
EPS (Basic) USD/shares	—	—	—	$0.37	-$0.09	-$0.47	$2.53	$0.75	$2.68	-$0.58	-$0.46	$0.06	-$0.89	$0.02	-$0.21	$0.32	$0.29	$0.23	—	—
EPS (Diluted) USD/shares	—	—	—	$0.37	-$0.09	-$0.47	$2.38	$0.70	$2.54	-$0.58	-$0.46	$0.06	-$0.89	$0.02	-$0.21	$0.32	$0.29	$0.23	—	—
Shares Outstanding (Basic Avg) shares	+1.1%	+0.9%	+0.1%	—	2.78M	2.76M	2.72M	2.69M	2.66M	2.66M	2.67M	2.69M	2.75M	2.75M	2.75M	2.74M	2.74M	2.74M	2.74M	2.74M
Shares Outstanding (Diluted Avg) shares	-1.3%	+0.9%	+0.1%	—	2.78M	2.76M	2.89M	2.89M	2.82M	2.66M	2.67M	2.7M	2.75M	2.75M	2.75M	2.75M	2.74M	2.74M	2.74M	2.74M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2019: $436K in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

0.28×

Peer median 1.50×

EV/EBIT

13.78×

Peer median 34.37×

P/E (TTM)

32.16×

Peer median 23.18×

Peer medians compare against the 72 similar-size Medical Devices companies (of 146 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component	FY2025	FY2024	FY2023
United States	$8,876,000	$10,429,000	$9,421,000
Mexico	$2,015,000	$2,445,000	$2,870,000
China	$1,328,000	$1,497,000	$1,139,000

By Product & Service (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Medical Imaging	$39,999,000	$37,492,000	$39,908,000	—	—	—
Medical Device	$31,930,000	$34,636,000	$38,758,000	—	—	—
Industrial	$30,940,000	$35,517,000	$40,113,000	$38,737,000	$35,482,000	$28,384,000
Aerospace and Defense	$15,496,000	$20,488,000	$20,553,000	$19,479,000	$16,639,000	$20,624,000
Medical	—	—	—	$75,907,000	$63,047,000	$55,098,000

Key facts CIK 722313 CUSIP 656553104 13F (30d) 15 filings 15 filers Visit website